Insider · CIK 0001612095

Haqq Christopher

CIK 0001612095 Name as filed on the most recent filing

Filed as Haqq Christopher (34)

50 transaction lines · from 34 filings · filed 2015-06-01 to 2019-02-19 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

50 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2019-02-15 S, Open-market sale Atara Biotherapeutics, Inc.ATRA 30,682, disposed Open Form 4 filing 0001209191-19-011187
2019-02-11 S, Open-market sale Atara Biotherapeutics, Inc.ATRA 538,736, disposed Open Form 4 filing 0001209191-19-009116
2019-02-06 S, Open-market sale Atara Biotherapeutics, Inc.ATRA 2 lines 477,922, disposed Open Form 4 filing 0001209191-19-008526
2018-11-15 S, Open-market sale Atara Biotherapeutics, Inc.ATRA 26,203, disposed Open Form 4 filing 0001209191-18-058763
2018-09-26 S, Open-market sale Atara Biotherapeutics, Inc.ATRA 581,580, disposed Open Form 4 filing 0001209191-18-052465
2018-09-25 S, Open-market sale Atara Biotherapeutics, Inc.ATRA 2 lines 546,905, disposed Open Form 4 filing 0001209191-18-052162
2018-09-24 S, Open-market sale Atara Biotherapeutics, Inc.ATRA 2 lines 718,425, disposed Open Form 4 filing 0001209191-18-052162
2018-08-15 S, Open-market sale Atara Biotherapeutics, Inc.ATRA 29,094, disposed Open Form 4 filing 0001209191-18-047107
2018-05-15 S, Open-market sale Atara Biotherapeutics, Inc.ATRA 3 lines 1,167,480, disposed Open Form 4 filing 0001209191-18-030722
2018-03-26 S, Open-market sale Atara Biotherapeutics, Inc.ATRA 2 lines 729,265, disposed Open Form 4 filing 0001209191-18-021728
2017-11-15 S, Open-market sale Atara Biotherapeutics, Inc.ATRA 21,429, disposed Open Form 4 filing 0001209191-17-061608
2017-10-16 S, Open-market sale Atara Biotherapeutics, Inc.ATRA 86,100, disposed Open Form 4 filing 0001209191-17-057159
2017-09-15 S, Open-market sale Atara Biotherapeutics, Inc.ATRA 91,800, disposed Open Form 4 filing 0001209191-17-053206
2017-08-15 S, Open-market sale Atara Biotherapeutics, Inc.ATRA 112,159, disposed Open Form 4 filing 0001209191-17-049448
2017-07-17 S, Open-market sale Atara Biotherapeutics, Inc.ATRA 89,520, disposed Open Form 4 filing 0001209191-17-045509
2017-06-15 S, Open-market sale Atara Biotherapeutics, Inc.ATRA 75,900, disposed Open Form 4 filing 0001209191-17-040561
2017-05-15 S, Open-market sale Atara Biotherapeutics, Inc.ATRA 113,984, disposed Open Form 4 filing 0001209191-17-033195
2017-04-17 S, Open-market sale Atara Biotherapeutics, Inc.ATRA 103,680, disposed Open Form 4 filing 0001209191-17-027470
2017-03-15 S, Open-market sale Atara Biotherapeutics, Inc.ATRA 117,600, disposed Open Form 4 filing 0001209191-17-021452
2017-02-15 S, Open-market sale Atara Biotherapeutics, Inc.ATRA 117,786, disposed Open Form 4 filing 0001209191-17-011764
2017-02-09 S, Open-market sale Atara Biotherapeutics, Inc.ATRA 216,054, disposed Open Form 4 filing 0001209191-17-009718
2017-01-17 S, Open-market sale Atara Biotherapeutics, Inc.ATRA 85,620, disposed Open Form 4 filing 0001209191-17-004333
2016-12-15 S, Open-market sale Atara Biotherapeutics, Inc.ATRA 92,400, disposed Open Form 4 filing 0001209191-16-155509
2016-11-21 S, Open-market sale Atara Biotherapeutics, Inc.ATRA 126,164, disposed Open Form 4 filing 0001209191-16-151797
2016-11-15 S, Open-market sale Atara Biotherapeutics, Inc.ATRA 32,000, disposed Open Form 4 filing 0001209191-16-150914
2016-08-15 S, Open-market sale Atara Biotherapeutics, Inc.ATRA 2 lines 30,041, disposed Open Form 4 filing 0001209191-16-137680
2016-05-16 S, Open-market sale Atara Biotherapeutics, Inc.ATRA 24,990, disposed Open Form 4 filing 0001209191-16-121434
2016-02-16 S, Open-market sale Atara Biotherapeutics, Inc.ATRA 49,499, disposed Open Form 4 filing 0001209191-16-100248
2015-08-31 S, Open-market sale Atara Biotherapeutics, Inc.ATRA 2 lines 209,961, disposed Open Form 4 filing 0001209191-15-068906
2015-08-17 S, Open-market sale Atara Biotherapeutics, Inc.ATRA 2 lines 73,632, disposed Open Form 4 filing 0001209191-15-067012
2015-07-31 S, Open-market sale Atara Biotherapeutics, Inc.ATRA 138,575, disposed Open Form 4 filing 0001209191-15-063312
2015-07-15 S, Open-market sale Atara Biotherapeutics, Inc.ATRA 2 lines 157,353, disposed Open Form 4 filing 0001209191-15-061030
2015-07-01 S, Open-market sale Atara Biotherapeutics, Inc.ATRA 2 lines 129,196, disposed Open Form 4 filing 0001209191-15-059119
2015-06-15 S, Open-market sale Atara Biotherapeutics, Inc.ATRA 3 lines 348,116, disposed Open Form 4 filing 0001209191-15-054001
2015-06-01 S, Open-market sale Atara Biotherapeutics, Inc.ATRA 3 lines 103,665, disposed Open Form 4 filing 0001209191-15-048430

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
Relationships on this page
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 50
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Haqq Christopher, insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001612095

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.